ReviewThe Lancet. Neurology2015

Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations.

Benjamin Dehay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.